Section 1115 demonstration authority is one of the most powerful vehicles available to states to test innovation in their Medicaid programs.
States use Section 1115 demonstrations to test innovations in their Medicaid programs.
The COVID-19 pandemic fundamentally changed Medicare and Medicaid health care service delivery.
Over the past 50-plus years, there have been enormous advances in understanding the mechanisms that cause blood cancer.
Approximately 12 million people in the United States are dually eligible for Medicare and Medicaid.
In 2021, drug-related overdose deaths topped 107,000.
Section 1115 demonstrations, also called “waivers,” allow states to test new ways to operate their Medicaid programs, typically for matters related to eligibility, benefits and care delivery.
Massachusetts’ historical achievements in innovative health care policy have positioned the state as a national leader in transforming health care coverage, access, affordability and quality.
Section 1115 Medicaid demonstrations are a powerful tool for states to pursue a range of innovative programs aimed at improving the health and well-being of Medicaid enrollees.
In 2020, health care spending in the United States increased by nearly 10 percent to reach $4.1 trillion, or 20 percent of the U.S. economy.